Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines.
Assumptions
Burden
Complexity
Cost-effectiveness
Influenza
Mathematical modelling
Next-generation vaccines
Vaccines
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
09 08 2023
09 08 2023
Historique:
received:
22
05
2023
accepted:
20
07
2023
medline:
11
8
2023
pubmed:
10
8
2023
entrez:
9
8
2023
Statut:
epublish
Résumé
We recently published an article in BMC Medicine looking at the potential health and economic impact of paediatric vaccination using next-generation influenza vaccines in Kenya: a modelling study. In their commentary on our article, Lafond et al. highlight the potential importance of the wider benefits of vaccination on cost-effectiveness. Whilst we agree with many points raised in the commentary, we think it raises further interesting discussion points, specifically around model complexity, model assumptions and data availability. These points are both relevant to this manuscript but have wider implications for vaccine cost-effectiveness studies.
Identifiants
pubmed: 37559086
doi: 10.1186/s12916-023-02996-3
pii: 10.1186/s12916-023-02996-3
pmc: PMC10411004
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Letter
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
301Commentaires et corrections
Type : CommentOn
Type : CommentOn
Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Vaccine. 2017 Nov 1;35(46):6255-6263
pubmed: 28986035
BMC Med. 2023 Mar 22;21(1):106
pubmed: 36949456
BMC Med. 2023 Jul 4;21(1):229
pubmed: 37400797